US-based Inbox Health raises US$ 15M in Series A funding

DOVER, Del. 10 April 2023 A broad range of post-acute care connection tools and solutions are provided by Profility Inc., a cloud-based, enterprise-grade platform. These tools and answers are simple to use and don’t require extensive interaction with other software or hardware. The platform, which utilizes current significant data sources and predictive analytics technologies to develop tailored care planning profiles, announced today that it had closed a Commercial Round led by Valitas VC, which has a unique strategy for enhancing the commercialization process (GTM). The fund is run by managers with extensive business backgrounds in the health, medtech, entrepreneurial, and capital sectors.

The business said Yaron Itzhari, Co-Founder and Managing Partner of Valitas VC, has been added to the Board of Directors.

According to Yaron Itzhari, Managing Partner of Valitas Ventures, “Profility and the platform are the subjects of great enthusiasm, and for a good reason. They are heading toward a brand-new, fully integrated AI profiling platform with sophisticated care-planning features and customized patient profiles.

Yaron Itzhari is accountable for the venture capital GTM investment strategy and vision as Co-Founder and Managing Partner of Valitas. Former CEO of Medtronic Israel before forming Valitas VC. Itzhari has 20 years of expertise in the medical technology and pharmaceutical industries. Itzhari established the Medtech Association in Israel and served as its board chairman.

About Profility:

By facilitating choices and transitions within the healthcare ecosystem, PROFILITY’s technology allows genuinely individualized care planning. Using profiling predictive analytics technologies and EMR summary approaches, Profility builds a transition profile to assist all key discharge decision points.

About Valitas:

A fund (VC) that focuses on investments in health tech is called Valitas. Valitas invests in businesses that have successfully achieved the scientific feasibility stage and are either about to finish the regulatory procedure or have already done so. The fund’s distinctive business plan enhances these businesses through better commercialization.

With the help of the VC model, businesses may go swiftly and easily from the development stage to full commercialization in the US and European markets. The fund is run by managers with extensive business backgrounds in the health, medtech, entrepreneurial, and capital sectors.

We try our  best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know

-if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by! Next Article

Previous articleSouth Korea-based blockchain startup Fingerlabs completes Series A funding
Next articleCold chain marketplace Celcius Logistics raises USD 12 million in Series A
Kshitij does business research and content writing for VCBay. Pursuing BBA from Symbiosis Center Of Management Studies (SCMS) Pune, he is skilled in Financial Modeling, Stock valuation and Microsoft Excel. He is passionate about Entrepreneurship and Finance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here